Viewing nowJinyang Ezetimibe Tablet
Ezetimibe 10mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201701414 · Approved 2017.03.24 · Insurance code 650303640
Treatment of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
This drug is used to lower elevated cholesterol and lipid levels in patients with primary hypercholesterolemia and homozygous familial hypercholesterolemia, and homozygous sitosterolemia. It is administered alone or in combination with other lipid-lowering agents as an adjunct to dietary therapy aimed at reducing total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, etc., in patients with hypercholesterolemia. It is also useful for patients with mixed hyperlipidemia and helps reduce non-high-density lipoprotein cholesterol (non-HDL-C) when used with fenofibrate. It is important to ensure that secondary causes of dyslipidemia, such as diabetes and hypothyroidism, are excluded before using this medication along with dietary therapy. Treatment should begin after accurate assessment of the condition through lipid testing, and patients with acute coronary events may also be included in treatment. This drug is effective in improving lipid abnormalities associated with hypercholesterolemia.
A standard cholesterol-lowering diet should be continued during treatment with this drug. The recommended dose of this drug is 10 mg once daily, with or without food. When this drug is administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate concomitant treatment with this drug at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this drug concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this drug is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Careful Administration). 2. Administration to patients with renal impairment No dose adjustment is necessary in patients with renal impairment. 3. Administration to elderly patients No dose adjustment is necessary when administered to elderly patients. 4. Concomitant administration with bile acid sequestrants This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).
This medication should not be used in patients who are allergic to any components of this drug. Patients with active liver disease or persistently elevated liver enzyme levels in blood tests should not use this drug in combination with certain types of lipid-lowering agents. Pregnant or breastfeeding women should not use this medication alongside certain lipid-lowering agents, and women of childbearing potential should consult with a physician. Patients with severe liver dysfunction, gallbladder disease, or severe kidney dysfunction should not take this drug in combination with specific lipid-lowering agents. This medication contains lactose, so it should not be taken by patients with lactose intolerance or specific genetic metabolic disorders. Patients with moderate to severe liver impairment may experience effects from this drug that differ from expectations, thus caution is advised. This drug can generally be used safely, but side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may occur. If symptoms like muscle pain or weakness arise, notify a physician immediately, and in severe cases, discontinuation of the medication may be necessary. When taken with other lipid-lowering agents or certain medications, potential interactions may occur, so follow the physician's directions. Consult with a physician before using this drug if you are pregnant or breastfeeding, and it is advisable to avoid use if possible. Use in children under 6 years of age is not recommended, and children or adolescents over 6 years should take it under a physician's guidance. Elderly patients can use this medication but should be carefully monitored considering age-related physiological differences. Patients with impaired kidney function may also use this medication, but dosage adjustments or regular examinations may be necessary. There is no specific treatment for overdose, and obtaining appropriate treatment according to symptoms is essential. This drug should be stored out of reach of children and kept in its original container for safety.
Fatigue, abdominal pain, diarrhea, viral infections, pharyngitis, sinusitis, joint pain, back pain, cough, chest pain, dizziness, headache, constipation, bloating, nausea, elevated AST, elevated ALT, myalgia, myopathy, rhabdomyolysis, elevated aminotransferase levels, gallbladder-related adverse reactions, cholelithiasis, cholecystitis, anaphylaxis, urticaria, rash, angioedema, thrombocytopenia, nausea, pancreatitis, sensory disturbances, depression, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanied by drug reactions, erythema multiforme, drug-induced liver injury, chest pain, discomfort in the chest, edema, weakness, systemic edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, dry mouth, discomfort in the epigastrium, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, conjunctival injection, renal failure, abnormal liver function, elevated serum creatine phosphokinase, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to avoid exposure to air or moisture. It is advisable to maintain a storage temperature between 1 degree Celsius and 30 degrees Celsius at room temperature. This helps to preserve the drug's efficacy for a longer period.
White to almost white oblong tablet
30 tablets (10 tablets x 3 PTP) (Material: Alu-Alu)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEzetimibe 10mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Shin Il Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.